Whitehawk Therapeutics (WHWK) Cash from Operations Growth (3y) (2013 - 2026)
Whitehawk Therapeutics (WHWK) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | -1.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39% |
| Dec 31, 2025 | -15.07% |
| Sep 30, 2025 | -23.34% |
| Jun 30, 2025 | -70.31% |
| Mar 31, 2025 | 15.14% |
| Dec 31, 2024 | -6.60% |
| Sep 30, 2024 | 3.35% |
| Jun 30, 2024 | -42.19% |
| Mar 31, 2024 | -56.87% |
| Dec 31, 2023 | -43.33% |
| Sep 30, 2023 | 8.84% |
| Jun 30, 2023 | -53.66% |
| Mar 31, 2023 | -75.54% |
| Dec 31, 2022 | -32.47% |
| Sep 30, 2022 | -19.83% |
| Jun 30, 2022 | -27.71% |
| Mar 31, 2022 | -28.84% |
| Dec 31, 2021 | -26.19% |
| Sep 30, 2021 | -40.82% |
| Jun 30, 2021 | -30.90% |